athenahealth wants to be the Amazon of healthcare

Cara Livernois | | Health Exec | Economics

We live in the age of technology where even babies use tablets, but it seems odd that while babies can use technology with ease our doctors are confounded by the internet. athenahealth hopes to change that by modeling their own “information problem” solution after top technology companies like Amazon.

“We’re going to do the same thing [as Jeff Bezos, CEO of Amazon],” Bush said, adding that his Massachusetts-based company has taken "a chunk of" the internet and made it secure enough to appeal to mainstream doctors.

Click the link below for the whole story: 

How athenahealth is trying to be the Amazon of health care

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Bill to regulate healthcare private equity lands on desk of Mass. governor
Mayo Clinic sues insurer over $740K in medical bills for patient
The biggest challenges facing radiology business managers in 2025
Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Radiology Business
Policies and regulations shaping radiology in 2025

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.